Pinatuzumab vedotin
- Generic Name
- Pinatuzumab vedotin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1313706-14-7
- Unique Ingredient Identifier
- 6KA1906BLC
- Background
Pinatuzumab vedotin is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)).
- Associated Conditions
- -
- Associated Therapies
- -
Pharmacovigilance study of the association between peripheral neuropathy and antibody
Article references on antibody-drug conjugates (ADCs) in cancer therapy, including comprehensive reviews, clinical trials, and analyses of toxicity and mechanisms.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath